Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HS-20094

RISE-1

Regeneron · Phase 3 · Not yet recruiting · Enrollment 3000

NCT07896265

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Olatorepatide-Dose 1n/rn/rn/rn/r
Olatorepatide-Dose 2n/rn/rn/rn/r
Olatorepatide-Dose 3n/rn/rn/rn/r
Placebo-Dose 1n/rn/rn/rn/r
Placebo-Dose 2n/rn/rn/rn/r

Not shown

  • Olatorepatide-Dose 1: endpoint not reported
  • Olatorepatide-Dose 2: endpoint not reported
  • Olatorepatide-Dose 3: endpoint not reported
  • Placebo-Dose 1: endpoint not reported
  • Placebo-Dose 2: endpoint not reported